Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Walker, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walker, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Journal Article

Molecular Genetics of Renal Carcinogenesis

Cheryl Walker

The University of Texas MD Anderson Cancer Center, Science Park Research Division, Park Road 1C, Smithville, Texas 78957

Renal cell carcinoma (RCC) is the most common tumor of the adult kidney, accounting for 85% of renal neoplasms. RCC is heterogeneous in appearance, displaying diverse histologic and cytologic characteristics, with the clear cell variant being the most common. Individuals at high risk for this disease include persons with end-stage renal disease, those with hereditary predispositions such as von Hippel-Lindau syndrome (VHL) or tuberous sclerosis (TSC), and individuals with significant environment exposures such as smoking or analgesic abuse. Recently, several of the genetic targets for alterations involved in the development of human RCC have been identified. Solid RCC of the clear cell type is associated with alterations in the VHL tumor suppressor gene and hereditary papillary RCC is associated with alterations of the c-met protooncogene. In the rat, the most commonly seen tumors are of the non-clear cell type and it is the Tsc-2 tumor suppressor gene, rather than the VHL tumor suppressor gene, that appears to be the primary target for both spontaneous and carcinogen-induced mutations in these animals. These data suggest that different variants of RCC have distinct molecular etiologies and that there are species-specific determinants that modulate the involvement of specific tumor suppressor genes in RCC. Interestingly, many of the genes involved in RCC also play significant roles in kidney development. The Wilm's tumor suppressor gene, WT-1, and Pax-2 regulate the mesenchymal epithelial transition that occurs during nephrogenesis and both these genes exhibit altered expression patterns and/or are mutated in renal tumors. Other genes such as c-met and its ligand hepatocyte growth factor are also involved in normal development and tumorigenesis, suggesting that tumors arise as a result of altered functions that are reflective of events that occur during nephrogenesis.

Key Words: Renal cell carcinoma • von Hippel-Lindau syndrome • tuberous sclerosis • tumor suppressor gene • tumorigenesis

Toxicologic Pathology, Vol. 26, No. 1, 113-120 (1998)
DOI: 10.1177/019262339802600113


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
N. J. Laping, J. I. Everitt, K. S. Frazier, M. Burgert, M. J. Portis, C. Cadacio, L. I. Gold, and C. L. Walker
Tumor-Specific Efficacy of Transforming Growth Factor-{beta}RI Inhibition in Eker Rats
Clin. Cancer Res., May 15, 2007; 13(10): 3087 - 3099.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H.-S. Yoon, S. Ramachandiran, M. A. S. Chacko, T. J. Monks, and S. S. Lau
Tuberous sclerosis-2 tumor suppressor modulates ERK and B-Raf activity in transformed renal epithelial cells
Am J Physiol Renal Physiol, February 1, 2004; 286(2): F417 - F424.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
K. S. Mcdorman and D. C. Wolf
Use of the Spontaneous Tsc2 Knockout (Eker) Rat Model of Hereditary Renal Cell Carcinoma for the Study of Renal Carcinogens
Toxicol Pathol, October 1, 2002; 30(6): 675 - 680.
[Abstract] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H.-S. Yoon, T. J. Monks, J. I. Everitt, C. L. Walker, and S. S. Lau
Cell proliferation is insufficient, but loss of tuberin is necessary, for chemically induced nephrocarcinogenicity
Am J Physiol Renal Physiol, August 1, 2002; 283(2): F262 - F270.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
D. C. Wolf, L. M. Crosby, M. H. George, S. R. Kilburn, T. M. Moore, R. T. Miller, and A. B. Deangelo
Time- and Dose-Dependent Development of Potassium Bromate-Induced Tumors in Male Fischer 344 Rats
Toxicol Pathol, November 1, 1998; 26(6): 724 - 729.
[Abstract] [PDF]